Polycomb repressive complex 2 mutations predict survival benefit in advanced cancer patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Vlachostergios, P. J. [1 ]
机构：
[1] Weill Cornell Med, Hematol & Med Oncol, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.01.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21P
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [1] ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
    Yi, Ruibin
    Lin, Anqi
    Cao, Manming
    Xu, Abai
    Luo, Peng
    Zhang, Jian
    FRONTIERS IN GENETICS, 2020, 11
  • [2] Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors
    Xiao, Lu-Shan
    Hu, Cheng-Yi
    Cui, Hao
    Li, Rui-Ning
    Hong, Chang
    Li, Qi-Mei
    Huang, Chao-Yi
    Dong, Zhong-Yi
    Zhu, Hong-Bo
    Liu, Li
    CANCER MEDICINE, 2022, 11 (24): : 4880 - 4888
  • [3] Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors
    Sen, Gulin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Guliyev, Murad
    Can, Guenay
    Turna, Hande
    Ozguroglu, Mustafa
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3264 - 3271
  • [4] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [5] A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
    van Not, Olivier J.
    Wind, Thijs T.
    Ismail, Rawa K.
    Bhattacharya, Arkajyoti
    Jalving, Mathilde
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    Haanen, John B.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    Fehrmann, Rudolf S. N.
    Hospers, Geke A. P.
    CANCERS, 2023, 15 (11)
  • [6] Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitors
    Kartolo, Adi
    Yeung, Cynthia
    Hopman, Wilma
    Fung, Andrea S.
    Baetz, Tara
    Badillo, Francisco E. Vera
    IMMUNOTHERAPY, 2022, 14 (10) : 777 - 787
  • [7] Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    Nunez, Nicolas Gonzalo
    Berner, Fiamma
    Friebel, Ekaterina
    Unger, Susanne
    Wyss, Nina
    Gomez, Julia Martinez
    Purde, Mette-Triin
    Niederer, Rebekka
    Porsch, Maximilian
    Lichtensteiger, Christa
    Kramer, Rafaela
    Erdmann, Michael
    Schmitt, Christina
    Heinzerling, Lucie
    Abdou, Marie-Therese
    Karbach, Julia
    Schadendorf, Dirk
    Zimmer, Lisa
    Ugurel, Selma
    Kluemper, Niklas
    Hoelzel, Michael
    Power, Laura
    Kreutmair, Stefanie
    Capone, Mariaelena
    Madonna, Gabriele
    Cevhertas, Lacin
    Heider, Anja
    Amaral, Teresa
    Ali, Omar Hasan
    Bomze, David
    Dimitriou, Florentia
    Diem, Stefan
    Ascierto, Paolo Antonio
    Dummer, Reinhard
    Jaeger, Elke
    Driessen, Christoph
    Levesque, Mitchell Paul
    van de Veen, Willem
    Joerger, Markus
    Frueh, Martin
    Becher, Burkhard
    Flatz, Lukas
    MED, 2023, 4 (02): : 113 - +
  • [8] Somatic mutations in genes associated with mismatch repair predict survival in patients with metastatic cancer receiving immune checkpoint inhibitors
    Liu, Yongping
    Chen, Lin
    Zhang, Shenli
    Shu, Yimei
    Qi, Qiufeng
    Zhu, Ming
    Peng, Yun
    Ling, Yang
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [9] Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Che, Hebin
    Xiong, Qi
    Ma, Jinxia
    Chen, Shixue
    Wu, Huan
    Xu, Hongli
    Hou, Baicun
    BMC CANCER, 2022, 22 (01)
  • [10] Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Hebin Che
    Qi Xiong
    Jinxia Ma
    Shixue Chen
    Huan Wu
    Hongli Xu
    Baicun Hou
    BMC Cancer, 22
12345